HCWB stock forecast
Our latest prediction for HCW Biologics Inc's stock price was made on the Sept. 19, 2023 when the stock price was at 2.13$.
In the short term (2weeks), HCWB's stock price should underperform the market by -3.27%. During that period the price should oscillate between -9.06% and +4.91%.
In the medium term (3months), HCWB's stock price should underperform the market by -8.44%. During that period the price should oscillate between -29.30% and +17.59%.
Get email alertsCreate a solid portfolio with HCWB
About HCW Biologics Inc
by leveraging our immunology expertise, hcw is developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell clearance.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -0.52$ per share.
The book value per share is -0.56$
Three months stock forecastSept. 19, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3M | 20.00% | -19M | -512.62% | -18M | -0.52 | - | - | - | -0.56 | - | - | - |